Cannabis Stock News: Abattis Bioceuticals
(OTCQB: $ATTBF) (CSE: $ATT) Gets Added to the Marijuana Index by MJIC
Vancouver, British Columbia - April 6, 2017 (Newsfile Corp.)
(Investorideas.com Newswire) Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE:
ATT) (the "Company" or "Abattis"), is pleased to announce
it has officially been added to The Marijuana Index, within the Biotechnology
sector.
The North American Marijuana Index tracks the leading public
cannabis companies operating in the United States and Canada and gives
investors up to date, centralized news on the securities deemed to be well
positioned within the multi-billion dollar cannabis industry. Selected
companies must meet stringent trading guidelines including having a minimum
market capitalization of $30 million and daily trading volumes of above $400K.
"We are delighted to have Abattis added to the The Marijuana
Index and look forward to sharing our story with investors closely tracking
this exciting sector," stated Abattis CFO, Rene David. "As we
approach sector legalization, we'll start to see markets broaden their reach
from the closely covered cultivation and growing players to those advancing the
technology and biosciences side of the cannabis industry," added Mr.
David.
Abattis' subsidiary Northern Vine Labs is set to open its doors
this month and will legally be able to test dried plant products, extracts,
derivatives and edibles for licensed producers and patients under the ACMPR
regulatory framework. Management will continue to provide timely updates on
these developments in the coming weeks.
About
Abattis Bioceuticals Corp.
Abattis is a specialty agricultural technology and biotechnology
company which aggregates, integrates, and invests in agricultural technologies
and biotechnology services for the legal cannabis industry developing in
Canada. The Company has successfully developed and licensed natural health
products, medicines, extractions, and ingredients for the biologics,
nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking
to acquire exclusive intellectual property rights to agricultural technologies
to be employed in extraction and processing of botanical ingredients and
compounds. The Company follows strict standard operating protocols, and adheres
to the applicable laws of Canada and foreign jurisdictions. For more
information, visit the Company's website at: www.abattis.com.
About
Northern Vine Canada Inc.
Northern Vine Labs™ is licensed by Health Canada (Dealers
License) for the possession of Cannabis and related active ingredients, as well
as the production of extracts for the purpose of analysis. Northern Vine Labs™
product certification and quality assurances programs incorporate global best
practices and procedures for application in the legal Canadian Cannabis market.
"Rene David"
Rene David, CFO, Director
Rene David, CFO, Director
For further information, contact the Company at (604) 336-0881
or at news@abattis.com.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use
of any of the words "anticipate", "continue",
"estimate", "expect", "may", "will",
"project", "should", "believe" and similar
expressions are intended to identify forward-looking statements. Although the
Company believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue reliance should not
be placed on the forward-looking statements because the Company can give no assurance
that they will prove to be correct. Since forward-looking statements address
future events and conditions, by their very nature they involve inherent risks
and uncertainties. These statements speak only as of the date of this press
release. Actual results could differ materially from those currently
anticipated due to a number of factors and risks various risk factors discussed
in the Company's Management's Discussion and Analysis under the Company's
profile on www.sedar.com. While the Company may elect to, it does not undertake
to update this information at any particular time. NEITHER THE CANADIAN
SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR
ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Watch the 420 Cannabis Investor video
More
Info:
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment